Girard Partners Ltd. Novartis Ag Transaction History

Girard Partners Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $170,404 - $209,728	-2,260 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $5,573 - $6,375	-74 Reduced 3.17%	2,260 $217,000
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $1,031 - $1,148	-14 Reduced 0.6%	2,334 $200,000
Q3 2018 Nov 09, 2018	BUY	$66.94 - $77.43 $157,175 - $181,805	2,348 New	2,348 $202,000
Q2 2018 Aug 07, 2018	SELL	$64.91 - $73.36 $177,204 - $200,272	-2,730 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$72.33 - $77.64 $7,233 - $7,764	-100 Reduced 3.53%	2,730 $229,000
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $209,816 - $218,674	2,830	2,830 $243,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Girard Partners Ltd. with notifications on news.